Trial intelligence / Profile preview

Perioperative liraglutide versus placebo for hyperglycaemia during cardiac surgery

NL-OMON29585Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Jun 2017
Modality
Peptides
Countries
1
01

Overview

Randomised, double-blind trial in hyperglycemia comparing Liraglutide with Placebo (2 arms). Primary endpoint: Proportion of patients needing perioperative insulin therapy. Started Jun 2017; status: active, not recruiting.

02

Drugs

03

Conditions

hyperglycemia

Beyond the preview

Go deeper on NL-OMON29585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON29585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call